Icon

MIRVASO (nda204708)- (EQ 0.33% BASE)

BRIMONIDINE TARTRATE GALDERMA LABS LP
EQ 0.33% BASE
Yes Yes
2031-Jun-13 Expired
None None
None No
MIRVASO (brimonidine) topical gel, 0.33% is an alpha adrenergic agonist indicated for the topical treatment of persistent (nontransient) facial erythema of rosacea in adults 18 years of age or older.
1 0 1
Total Other Developers None
Drugs with Suitability No
EQ 0.33% BASE ** ** - - 1
NDA Sales Available Total Generic Sales Available
Yes 1
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ******* ****** ******* ****** *************** *** *********** * ********* ***, *******, *******, ****** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.